chartexchange

Belgian startup revives Galapagos CAR-T research

BioPharma Dive | Oct 15, 2026 11:55 AM EDT

Armed Cell Therapeutics, chaired by former Galapagos CEO Paul Stoffels, has assumed control of cell therapies the company — now known as Lakefront Biotherapeutics — divested in a strategic overhaul.

Read original article